DNA - Ginkgo Bioworks Holdings, Inc.
6.5
-0.340 -5.231%
Share volume: 940,284
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$6.84
-0.34
-0.05%
Summary score
34%
Profitability
35%
Dept financing
32%
Liquidity
50%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-7.01%
Return on sales
-212.41%
Return on invested capital
0%
Total debt ratio
51.37%
Debt ratio change over timeo
0%
Current Ratio
4.95%
Quick Ratio
0%
Cash Position Ratio
2.66%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-6.87%
Return on sales
-204.45%
Return on invested capital
0%
Total debt ratio
52.48%
Debt ratio change over timeo
0%
Current Ratio
4.73%
Quick Ratio
0%
Cash Position Ratio
1.8%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-5.82%
Return on sales
-197.44%
Return on invested capital
0%
Total debt ratio
54.58%
Debt ratio change over time
0%
Current Ratio
4.92%
Quick Ratio
0%
Cash Position Ratio
1.74%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | DNA | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 5.97% | 8.91% |
| Return on assets | -7.01% | 2.97% | 3.34% | 2.04% |
| Return on sales | -212.41% | 27.71% | 27.82% | 21.49% |
| Return on invested capital | 0% | 0% | 3.51% | 10.25% |
| Profitability | 0% | 47% | 75% | 85% |
| Total debt ratio | 51.37% | 93.27% | 65.75% | 43.64% |
| Debt ratio change over time | 0% | 14.34% | 187.33% | 9.75% |
| Dept financing | 14% | 27% | 43% | 13% |
| Current Ratio | 4.73% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 0% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 1.8% | 0.39% | 0.58% | 0.86% |
| Liquididy | 50% | 35% | 29% | 43% |
| Short-term ratios | DNA | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -6.87% | 3.27% | 4.7% | 1.36% |
| Return on sales | -204.45% | 24.35% | 34.09% | 15.11% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 35% | 50% | 18% |
| Total debt ratio | 52.48% | 91.09% | 63.87% | 38.21% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 39% | 25% | 18% | 10% |
| Current Ratio | 4.73% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 0% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 1.8% | 0.39% | 0.58% | 0.86% |
| Liquididy | 50% | 26% | 34% | 49% |